Hits: 1722 img
IOTA LSR 3930 Series (50–70 Shore A) is a two-component addition-cure liquid silicone rubber specially designed for producing medical-grade silicone tubing. Main features include excellent biocompatibility, two-component 1:1 mixing ratio, excellent mold release, fast heat curing, and excellent mechanical properties. The typical application is medical-purpose silicone tubing. Technical data give three hardness grades: 3930-50, 3930-60, and 3930-70, with cured hardness of 50, 60, and 70; tensile strength of about 10, 9, and 9 MPa; elongation of about 500%, 400%, and 340%; tear strength of about 40, 35, and 32 kN/m; density of about 1.12, 1.13, and 1.14 g/cm³; and a note stating compliance with ISO 10993.
The curing time section only says “see curing time” and does not give a specific temperature-time table; actual curing conditions should be obtained from the supplier or confirmed with the equipment and product structure.
Selection should not rely only on “medical grade,” “ISO 10993 compliance,” or “hardness 50–70.” First confirm the tubing specification and use, contact mode, sterilization method and cycles, extrusion or molding method, same-batch A/B 1:1 metering and mixing, whether the material is thoroughly stirred, curing temperature and time, hardness grade selection, and the biocompatibility test items and regulatory compliance documents required by the project. This article does not equate “ISO 10993 compliance” with final medical device compliance, nor does it extend “medical-purpose silicone tubing” to all medical devices. IOTA can provide liquid silicone rubber raw materials and corresponding product data; the company does not provide complete formulations or formulation development services.
The series is used for medical-purpose silicone tubing. Different tubing applications focus on different points: infusion or drainage tubing on softness, transparency, rebound, and sterilization resistance; other medical tubing on hardness, pressure resistance, dimensional stability, and tear strength. Within the series, hardness ranges from 50 to 70 across 3930-50 to 3930-70. Selection should start with tube diameter, wall thickness, forming method, contact mode, and sterilization method, not just “medical grade” or “pick a hardness.”
| What to confirm | What to specify in an inquiry or sample request |
|---|---|
| Medical application and contact mode | Specific use of the medical silicone tubing; body contact site, contact duration, short-term or long-term contact |
| Regulation and biocompatibility | Specific ISO 10993 test items, regulatory requirements, customer restricted-substance list; test reports and compliance documents required |
| Sterilization method | Sterilization method (e.g., ethylene oxide, irradiation, steam), number of cycles, post-sterilization performance requirements |
| Tubing specification and forming | Tube diameter, wall thickness, length, extrusion or molding method, die or mold, release requirements |
| Mixing and metering | Two-component A:B = 1:1; only same-batch A/B may be mixed; metering accuracy, mixing uniformity, and feeding equipment |
| Material pretreatment | Whether thoroughly stirred before transfer to container; whether fillers or colorants are uniformly dispersed |
| Curing conditions | Curing temperature and time; the data only say “see curing time,” so obtain from the supplier and confirm with tube wall thickness and equipment |
| Hardness grade selection | 3930-50/60/70; select with tube diameter, wall thickness, softness, pressure resistance, rebound, and post-sterilization performance |
| Acceptance criteria | Hardness, tensile strength, tear strength, elongation, compression set, rebound, sterilization resistance, transparency, biocompatibility, etc. |
| Sample preparation | Sample size, wall thickness, forming method, vulcanization conditions, secondary heating, whether evaluated after sterilization, sample quantity |
If the customer already has a test specification, obtain the original document first. When criteria are missing, confirm them with the project owner and test laboratory before making samples, so that both sides do not discover different interpretations of “pass” after testing.
IOTA LSR 3930 Series uses a two-component 1:1 mixing ratio. Important notes: the series is platinum-catalyzed, with the platinum catalyst in Component A; strict care is required during use to avoid catalyst poisoning. Only Component A and Component B of the same batch number may be mixed together. To ensure optimum flow and uniformity, the material must be thoroughly stirred before transfer into a container.
The curing time section only says “see curing time” and does not provide a specific temperature-time table. Therefore, sample-request and acceptance documents should not simply apply conditions from other series. Obtain the current batch curing recommendation from the supplier and confirm it with the tube wall thickness, forming method, mold temperature, and feeding equipment. A tack-free or briefly set film does not necessarily mean the final curing condition has been reached.
The product note states compliance with ISO 10993. ISO 10993 is a set of biocompatibility evaluation standards containing multiple specific test items; raw-material “ISO 10993 compliance” should be understood as results under specific test items and is not the same as automatic compliance of the final medical device. For medical-purpose silicone tubing, obtain the corresponding test reports and regulatory compliance documents, and evaluate according to the specific contact site, contact duration, sterilization method, and customer requirements. The final product must also be evaluated with formulation, process, additives, vulcanization conditions, and sterilization conditions.
“Medical-purpose silicone tubing” is a product positioning description and should not be extended to mean suitability for all medical devices. Other medical devices should separately confirm hardness, biocompatibility, sterilization resistance, and regulatory requirements.
Technical data: 3930-50/60/70 cured hardness 50/60/70, tensile strength 10/9/9 MPa, elongation 500%/400%/340%, tear strength 40/35/32 kN/m, and density about 1.12/1.13/1.14 g/cm³. As hardness increases, elongation decreases and tear strength slightly decreases. Selection should be confirmed with tube diameter, wall thickness, softness, pressure resistance, rebound, and post-sterilization performance, not hardness alone.
Mold release and mechanical properties should also be evaluated with the specific forming method and process. Release performance depends on die or mold material, surface condition, tubing structure, and cure degree. Whether mechanical properties are retained after sterilization should be tested separately. If tubing transparency is a project requirement, it should also be confirmed separately at the target wall thickness and after sterilization; raw-material appearance alone is not sufficient.
Obtain the customer’s service conditions, regulatory requirements, and acceptance criteria; confirm whether the medical application, contact mode, sterilization method, ISO 10993 items, and hardness grade requirements are targets or existing results.
Specify tubing specification and wall thickness, forming method, same-batch A:B = 1:1 mixing/metering, material stirring, curing temperature and time, sterilization arrangement, and hardness grade.
Check the current IOTA LSR 3930 Series data, batch data, and biocompatibility reports, then have the user make representative samples and keep records of mixing, forming, vulcanization, release, sterilization, and post-treatment.
Arrange tests as agreed; keep sample identity, test conditions, observation photos, and evaluation results in the report. Before expanding use, confirm whether the samples represent actual tubing.
IOTA/Anhui Iota Silicone Oil Co., Ltd. positions itself as a solution provider across the organosilicon industry chain and can provide liquid silicone rubber raw materials and corresponding product data. When communicating, provide the tubing specification, forming method, contact mode, sterilization method, regulatory requirements, mold, and curing equipment together to facilitate candidate screening; the company does not provide complete formulations or formulation development services.
No. ISO 10993 contains multiple specific test items. Raw-material compliance with specific items is not the same as automatic compliance of the final medical device; evaluation must also consider contact site, contact duration, sterilization method, and regulatory requirements.
Not recommended. Obtain the current batch curing recommendation from the supplier and confirm it with the tube wall thickness, forming method, mold temperature, and feeding equipment.
Select with tube diameter, wall thickness, softness, pressure resistance, rebound, assembly requirements, and post-sterilization performance, not hardness alone. As hardness increases, elongation decreases and tear strength slightly decreases.
The data explicitly require that only Component A and Component B of the same batch number be mixed together. Mixing different batches may affect metering, curing, and property consistency; follow the customer’s raw-material management and supplier requirements.
The platinum catalyst is in Component A. Strict care is required during use to avoid contact with substances known to poison platinum catalysts. Specific material compatibility should be included in the customer’s raw-material approval and site management requirements.
The data do not give post-sterilization property data. Hardness, tensile strength, tear strength, rebound, dimensional changes, and transparency should be tested separately with the actual sterilization method and number of cycles; unsterilized data cannot be used to infer post-sterilization performance directly.
No direct extrapolation. Other medical devices should separately confirm hardness, biocompatibility, sterilization resistance, and regulatory requirements, and obtain corresponding test evidence.